Earlier is better when treating rheumatoid arthritis: but can we detect a window of opportunity?
Sign Up to like & getrecommendations! Published in 2020 at "RMD Open"
DOI: 10.1136/rmdopen-2020-001242
Abstract: Objectives The window of opportunity (WOO) hypothesis suggests a limited time frame to stop rheumatoid arthritis (RA). We hypothesised that a WOO could either be represented by a hyperbolic (‘curved’) decline in the chance to… read more here.
Keywords: slow acting; chance achieve; treatment; rheumatoid arthritis ... See more keywords
[Reduction of social coverage for symptomatic slow-acting drugs for osteoarthritis: a disinvestment initiative in Argentina, 2015-2017].
Sign Up to like & getrecommendations! Published in 2021 at "Salud colectiva"
DOI: 10.18294/sc.2021.3246
Abstract: In April 2016, the National Institute of Social Services for Retirees and Pensioners discontinued its policy of 100% coverage for 159 drugs (the "social subsidy"), including symptomatic slow-acting drugs for osteoarthritis (SYSADOAs), due to insufficient… read more here.
Keywords: slow acting; acting drugs; coverage; symptomatic slow ... See more keywords
Effects of Slow-Acting Metformin Treatment on the Hormonal and Morphological Thyroid Profile in Patients with Insulin Resistance
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14101987
Abstract: Metformin appears to reduce TSH levels in untreated hypothyroid patients. In contrast, in euthyroid patients with type 2 diabetes mellitus (T2DM), metformin is initially devoid of effects on TSH. However, it is followed by a… read more here.
Keywords: insulin resistance; acting metformin; treatment; slow acting ... See more keywords